These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16515500)

  • 1. Alpha2-antiplasmin on cardiovascular diseases.
    Matsuno H
    Curr Pharm Des; 2006; 12(7):841-7. PubMed ID: 16515500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
    Matsuno H; Kozawa O; Yoshimi N; Akamatsu S; Hara A; Mori H; Okada K; Ueshima S; Matsuo O; Uematsu T
    Blood; 2002 Oct; 100(7):2487-93. PubMed ID: 12239160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.
    Matsuno H; Okada K; Ueshima S; Matsuo O; Kozawa O
    J Thromb Haemost; 2003 Aug; 1(8):1734-9. PubMed ID: 12911586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of alpha 2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice.
    Matsuno H; Ishisaki A; Nakajima K; Okada K; Ueshima S; Matsuo O; Kozawa O
    Blood; 2003 Nov; 102(10):3621-8. PubMed ID: 12893771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
    Dewerchin M; Collen D; Lijnen HR
    Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
    Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
    Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
    Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T
    Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of alpha 2-antiplasmin enhances ADP induced platelet micro-aggregation through the presence of excess active plasmin in mice.
    Takei M; Matsuno H; Okada K; Ueshima S; Matsuo O; Kozawa O
    J Thromb Thrombolysis; 2002 Dec; 14(3):205-11. PubMed ID: 12913400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene targeting in hemostasis. Alpha2-antiplasmin.
    Lijnen HR
    Front Biosci; 2001 Feb; 6():D239-47. PubMed ID: 11171550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kidney is a major site of alpha(2)-antiplasmin production.
    Menoud PA; Sappino N; Boudal-Khoshbeen M; Vassalli JD; Sappino AP
    J Clin Invest; 1996 Jun; 97(11):2478-84. PubMed ID: 8647939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of alpha2-antiplasmin improves cutaneous wound healing via over-released vascular endothelial growth factor-induced angiogenesis in wound lesions.
    Kanno Y; Hirade K; Ishisaki A; Nakajima K; Suga H; Into T; Matsushita K; Okada K; Matsuo O; Matsuno H
    J Thromb Haemost; 2006 Jul; 4(7):1602-10. PubMed ID: 16839360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasmin.
    Robbie LA; Bennett B; Keyt BA; Booth NA
    Br J Haematol; 2000 Nov; 111(2):517-23. PubMed ID: 11122093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of both α2-antiplasmin and plasminogen activator inhibitor type-1 induces high IgE production.
    Okada K; Ueshima S; Kawao N; Yano M; Tamura Y; Tanaka M; Sakamoto A; Hatano M; Arima M; Miyata S; Nagai N; Tokuhisa T; Matsuo O
    Life Sci; 2013 Jul; 93(2-3):89-95. PubMed ID: 23770230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.
    Carmeliet P; Moons L; Dewerchin M; Mackman N; Luther T; Breier G; Ploplis V; Müller M; Nagy A; Plow E; Gerard R; Edgington T; Risau W; Collen D
    Ann N Y Acad Sci; 1997 Apr; 811():191-206. PubMed ID: 9186598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding.
    Lijnen HR; Okada K; Matsuo O; Collen D; Dewerchin M
    Blood; 1999 Apr; 93(7):2274-81. PubMed ID: 10090937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
    Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
    J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.